Annual Cost Of Goods Sold
$671.00 K
-$57.00 K-7.83%
31 December 2023
Summary:
Lineage Cell Therapeutics annual cost of goods sold is currently $671.00 thousand, with the most recent change of -$57.00 thousand (-7.83%) on 31 December 2023. During the last 3 years, it has risen by +$286.00 thousand (+74.29%). LCTX annual cost of goods sold is now -52.95% below its all-time high of $1.43 million, reached on 31 December 2021.LCTX Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$38.00 K
-$6000.00-13.64%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly cost of goods sold is currently $38.00 thousand, with the most recent change of -$6000.00 (-13.64%) on 30 September 2024. Over the past year, it has dropped by -$131.00 thousand (-77.51%). LCTX quarterly cost of goods sold is now -96.14% below its all-time high of $985.00 thousand, reached on 30 September 2021.LCTX Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$436.00 K
-$131.00 K-23.10%
30 September 2024
Summary:
Lineage Cell Therapeutics TTM cost of goods sold is currently $436.00 thousand, with the most recent change of -$131.00 thousand (-23.10%) on 30 September 2024. Over the past year, it has dropped by -$81.00 thousand (-15.67%). LCTX TTM cost of goods sold is now -72.41% below its all-time high of $1.58 million, reached on 30 June 2022.LCTX TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | -77.5% | -15.7% |
| 3 y3 years | +74.3% | -96.1% | -67.4% |
| 5 y5 years | +122.2% | -66.7% | +27.9% |
LCTX Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -53.0% | +74.3% | -96.1% | at low | -72.4% | at low |
| 5 y | 5 years | -53.0% | +122.2% | -96.1% | at low | -72.4% | +27.9% |
| alltime | all time | -53.0% | +988.7% | -96.1% | +290.0% | -72.4% | +678.3% |
Lineage Cell Therapeutics Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $38.00 K(-13.6%) | $436.00 K(-23.1%) |
| June 2024 | - | $44.00 K(-55.1%) | $567.00 K(-12.8%) |
| Mar 2024 | - | $98.00 K(-61.7%) | $650.00 K(-3.1%) |
| Dec 2023 | $671.00 K(-7.8%) | $256.00 K(+51.5%) | $671.00 K(+29.8%) |
| Sept 2023 | - | $169.00 K(+33.1%) | $517.00 K(-11.3%) |
| June 2023 | - | $127.00 K(+6.7%) | $583.00 K(-13.1%) |
| Mar 2023 | - | $119.00 K(+16.7%) | $671.00 K(-7.8%) |
| Dec 2022 | $728.00 K(-48.9%) | $102.00 K(-56.6%) | $728.00 K(-12.3%) |
| Sept 2022 | - | $235.00 K(+9.3%) | $830.00 K(-47.5%) |
| June 2022 | - | $215.00 K(+22.2%) | $1.58 M(+6.0%) |
| Mar 2022 | - | $176.00 K(-13.7%) | $1.49 M(+4.5%) |
| Dec 2021 | $1.43 M(+270.4%) | $204.00 K(-79.3%) | $1.43 M(+6.7%) |
| Sept 2021 | - | $985.00 K(+688.0%) | $1.34 M(+194.9%) |
| June 2021 | - | $125.00 K(+11.6%) | $453.00 K(+12.4%) |
| Mar 2021 | - | $112.00 K(-1.8%) | $403.00 K(+4.7%) |
| Dec 2020 | $385.00 K(-6.6%) | $114.00 K(+11.8%) | $385.00 K(-2.3%) |
| Sept 2020 | - | $102.00 K(+36.0%) | $394.00 K(-3.0%) |
| June 2020 | - | $75.00 K(-20.2%) | $406.00 K(-7.3%) |
| Mar 2020 | - | $94.00 K(-23.6%) | $438.00 K(+6.3%) |
| Dec 2019 | $412.00 K(+36.4%) | $123.00 K(+7.9%) | $412.00 K(+20.8%) |
| Sept 2019 | - | $114.00 K(+6.5%) | $341.00 K(+30.2%) |
| June 2019 | - | $107.00 K(+57.4%) | $262.00 K(+0.4%) |
| Mar 2019 | - | $68.00 K(+30.8%) | $261.00 K(-13.6%) |
| Dec 2018 | $302.00 K(+79.8%) | $52.00 K(+48.6%) | $302.00 K(-0.7%) |
| Sept 2018 | - | $35.00 K(-67.0%) | $304.00 K(-5.3%) |
| June 2018 | - | $106.00 K(-2.8%) | $321.00 K(+45.9%) |
| Mar 2018 | - | $109.00 K(+101.9%) | $220.00 K(+31.0%) |
| Dec 2017 | $168.00 K(-53.1%) | $54.00 K(+3.8%) | $168.00 K(+78.7%) |
| Sept 2017 | - | $52.00 K(+940.0%) | $94.00 K(-6.0%) |
| June 2017 | - | $5000.00(-91.2%) | $100.00 K(-47.4%) |
| Mar 2017 | - | $57.00 K(-385.0%) | $190.00 K(-46.9%) |
| Dec 2016 | $358.00 K | -$20.00 K(-134.5%) | $358.00 K(-32.2%) |
| Sept 2016 | - | $58.00 K(-38.9%) | $528.00 K(-41.5%) |
| June 2016 | - | $95.00 K(-57.8%) | $902.00 K(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $225.00 K(+50.0%) | $1.07 M(-3.5%) |
| Dec 2015 | $1.11 M(+32.3%) | $150.00 K(-65.3%) | $1.11 M(-6.2%) |
| Sept 2015 | - | $432.00 K(+66.2%) | $1.18 M(+20.6%) |
| June 2015 | - | $260.00 K(-1.5%) | $978.00 K(+0.8%) |
| Mar 2015 | - | $264.00 K(+18.4%) | $970.00 K(+15.8%) |
| Dec 2014 | $837.00 K(+5.5%) | $223.00 K(-3.5%) | $837.90 K(+0.0%) |
| Sept 2014 | - | $231.00 K(-8.3%) | $837.70 K(+3.0%) |
| June 2014 | - | $252.00 K(+91.1%) | $813.40 K(+9.6%) |
| Mar 2014 | - | $131.90 K(-40.8%) | $742.20 K(-6.4%) |
| Dec 2013 | $793.00 K(+82.6%) | $222.80 K(+7.8%) | $793.00 K(+8.5%) |
| Sept 2013 | - | $206.70 K(+14.3%) | $730.60 K(+5.3%) |
| June 2013 | - | $180.80 K(-1.0%) | $693.60 K(+16.2%) |
| Mar 2013 | - | $182.70 K(+13.9%) | $596.70 K(+37.4%) |
| Dec 2012 | $434.30 K(+447.0%) | $160.40 K(-5.5%) | $434.30 K(+47.5%) |
| Sept 2012 | - | $169.70 K(+102.3%) | $294.50 K(+105.5%) |
| June 2012 | - | $83.90 K(+313.3%) | $143.30 K(+70.2%) |
| Mar 2012 | - | $20.30 K(-1.5%) | $84.20 K(+31.8%) |
| Dec 2011 | $79.40 K(+186.6%) | $20.60 K(+11.4%) | $63.90 K(-10.0%) |
| Sept 2011 | - | $18.50 K(-25.4%) | $71.00 K(+35.2%) |
| June 2011 | - | $24.80 K(-10.5%) | $52.50 K(+89.5%) |
| Dec 2010 | $27.70 K(-136.7%) | $27.70 K(-243.5%) | $27.70 K(-136.7%) |
| Dec 2000 | -$75.50 K(+26.9%) | -$19.30 K(0.0%) | -$75.40 K(+34.4%) |
| Sept 2000 | - | -$19.30 K(+4.3%) | -$56.10 K(+52.4%) |
| June 2000 | - | -$18.50 K(+1.1%) | -$36.80 K(+101.1%) |
| Mar 2000 | - | -$18.30 K(-109.1%) | -$18.30 K(-109.1%) |
| Dec 1999 | -$59.50 K(-109.9%) | - | - |
| Sept 1995 | - | $200.00 K(0.0%) | $200.00 K(-71.4%) |
| Dec 1993 | - | $200.00 K(0.0%) | $700.00 K(0.0%) |
| Sept 1993 | - | $200.00 K(0.0%) | $700.00 K(+16.7%) |
| June 1993 | $600.00 K(+50.0%) | $200.00 K(+100.0%) | $600.00 K(0.0%) |
| Mar 1993 | - | $100.00 K(-50.0%) | $600.00 K(0.0%) |
| Dec 1992 | - | $200.00 K(+100.0%) | $600.00 K(+50.0%) |
| Sept 1992 | - | $100.00 K(-50.0%) | $400.00 K(+33.3%) |
| June 1992 | $400.00 K | $200.00 K(+100.0%) | $300.00 K(+200.0%) |
| Mar 1992 | - | $100.00 K | $100.00 K |
FAQ
- What is Lineage Cell Therapeutics annual cost of goods sold?
- What is the all time high annual cost of goods sold for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual cost of goods sold year-on-year change?
- What is Lineage Cell Therapeutics quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly cost of goods sold year-on-year change?
- What is Lineage Cell Therapeutics TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics TTM cost of goods sold year-on-year change?
What is Lineage Cell Therapeutics annual cost of goods sold?
The current annual cost of goods sold of LCTX is $671.00 K
What is the all time high annual cost of goods sold for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual cost of goods sold is $1.43 M
What is Lineage Cell Therapeutics annual cost of goods sold year-on-year change?
Over the past year, LCTX annual cost of goods sold has changed by -$57.00 K (-7.83%)
What is Lineage Cell Therapeutics quarterly cost of goods sold?
The current quarterly cost of goods sold of LCTX is $38.00 K
What is the all time high quarterly cost of goods sold for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly cost of goods sold is $985.00 K
What is Lineage Cell Therapeutics quarterly cost of goods sold year-on-year change?
Over the past year, LCTX quarterly cost of goods sold has changed by -$131.00 K (-77.51%)
What is Lineage Cell Therapeutics TTM cost of goods sold?
The current TTM cost of goods sold of LCTX is $436.00 K
What is the all time high TTM cost of goods sold for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high TTM cost of goods sold is $1.58 M
What is Lineage Cell Therapeutics TTM cost of goods sold year-on-year change?
Over the past year, LCTX TTM cost of goods sold has changed by -$81.00 K (-15.67%)